Patent · US Active

Compounds

US9422272B2 · kind B2 · utility

10Cited by
6References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2015
Grant dateAug 23, 2016
Priority date—
Expiry dateAug 3, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I):are described herein. Compounds of the disclosure are modulators of Kv3 channels and may be used in the prophylaxis or treatment of related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.